- Home
- BRNS vs HHS Comparison
BRNS vs HHS Comparison
Compare BRNS & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRNS
- HHS
- Stock Information
- Founded
- BRNS 2016
- HHS 1923
- Country
- BRNS United Kingdom
- HHS United States
- Employees
- BRNS N/A
- HHS N/A
- Industry
- BRNS Biotechnology: Pharmaceutical Preparations
- HHS Advertising
- Sector
- BRNS Health Care
- HHS Consumer Discretionary
- Exchange
- BRNS Nasdaq
- HHS Nasdaq
- Market Cap
- BRNS 52.0M
- HHS 55.0M
- IPO Year
- BRNS 2021
- HHS N/A
- Fundamental
- Price
- BRNS $1.21
- HHS $7.27
- Analyst Decision
- BRNS Strong Buy
- HHS
- Analyst Count
- BRNS 2
- HHS 0
- Target Price
- BRNS $4.00
- HHS N/A
- AVG Volume (30 Days)
- BRNS 39.7K
- HHS 16.2K
- Earning Date
- BRNS 11-07-2024
- HHS 11-07-2024
- Dividend Yield
- BRNS N/A
- HHS N/A
- EPS Growth
- BRNS N/A
- HHS N/A
- EPS
- BRNS N/A
- HHS N/A
- Revenue
- BRNS N/A
- HHS $187,093,000.00
- Revenue This Year
- BRNS $27.18
- HHS N/A
- Revenue Next Year
- BRNS N/A
- HHS $4.05
- P/E Ratio
- BRNS N/A
- HHS N/A
- Revenue Growth
- BRNS N/A
- HHS N/A
- 52 Week Low
- BRNS $1.11
- HHS $5.39
- 52 Week High
- BRNS $5.10
- HHS $8.87
- Technical
- Relative Strength Index (RSI)
- BRNS 45.13
- HHS 44.49
- Support Level
- BRNS $1.15
- HHS $6.66
- Resistance Level
- BRNS $1.35
- HHS $7.41
- Average True Range (ATR)
- BRNS 0.07
- HHS 0.25
- MACD
- BRNS 0.01
- HHS -0.03
- Stochastic Oscillator
- BRNS 30.00
- HHS 55.66
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic that guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer.
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.